Our Team

Eran Lerer is the CEO and Managing Partner of Shoni Health Ventures.

Previously, Eran was a Principal at aMoon, a $1.3B HealthTech fund, where he led due diligence processes from initiation to investment and thereafter, served on boards and supported CEOs in complex strategic processes.

Eran has a strong background in business development, marketing and sales in Medical Devices, Digital Health, Pharmaceuticals, Diagnostics, and Medical Nutrition from his 20 years of experience in these fields. At Abbott, where he worked for 9 years prior to aMoon and earned a number of global Excellence Awards, Eran held increasingly senior roles both in Israel and in the US. Ultimately, Eran was part of Abbott Israel’s management team, and led one of the Company’s business units with full P&L responsibilities.

Prior to Abbott, Eran worked at Johnson & Johnson in medical device sales and at Evogene in R&D and Business Development.

Eran earned his B.Sc. in Biotechnology Engineering from Ben-Gurion University and his MBA from the University of Michigan, Ross School of Business.

Sara Greenberg is the Co-founder of Shoni Health Ventures.

Sara is originally from Philadelphia and has lived and worked in the US, China and Israel, in roles spanning corporate strategy, venture capital and social finance. In 2015, Sara made Aliyah to Israel and completed a voluntary service in an elite intelligence unit in the Israel Defense Forces. She served as the Prime Minister of Israel’s Advisor for Foreign Affairs and today remains active in political and social affairs while also managing a family investment office. She also chairs the impact investment arm of the Seed the Dream Foundation, focused on empowering women and fostering educational opportunities for marginalized communities in Israel.

Sara also started InsideIL, a non-profit organization that sends MBA students to Israel for summer internships. She also played in the Women’s Lacrosse World Cup on the Israeli national team and today sits on the Israel Lacrosse Board. Moreover, she volunteers with numerous organizations involved with Israel and Holocaust education.

Sara earned her BA in Economics from Yale University and holds a Joint Master’s degree in Business Administration and Public Policy from Harvard Kennedy School and Harvard Business School.

Ran is the Co-founder of Shoni Health Ventures.

Ran is a board-certified Gynecologic Oncologist and the Founder and Chairman of N1X10, which builds the world’s first market network for cancer patients and cancer experts providing advocacy services.

In 2011, Ran founded Eliaso, supporting cancer patients seeking professional partnering and collaborative decision-making beyond the boundaries of the healthcare system. Ran led the life-sciences investment arm of Israel Seed Partners, served as CEO at GI View, and served as Chief Medical Officer at dbMotion and Medial Early Sign.

Ran holds an MD from the Hadassah Medical School at the Hebrew University of Jerusalem and earned his board certification in Obstetrics and Gynecology from Hadassah Mount Scopus Hospital. He was certified as a Gynecologic Oncologist at the University of Toronto and earned a Ph.D. from the Hebrew University. Ran published over 40 papers in peer-reviewed medical journals, as well as several chapters in books dealing with cancer and genetics. He is a reviewer and member of the Society for Gynecologic Investigation.

Eyal is the Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center and the founder of Sheba’s global innovation arm, ARC. He is an internal medicine physician, a healthcare executive and a researcher focused on assessing and improving healthcare quality and value, patient engagement and patient safety.

Prior to his work at Sheba, Eyal held the position of Lead Researcher at Mass General Brigham Clinical Affairs Department in Boston. During that time, he held an appointment at Brigham and Women’s Hospital and Harvard Medical School affiliated Center for Patient Safety Research and Practice.

Eyal is also a founding member of the International Academy of Quality and Safety in Healthcare and an international expert at the International Society of Quality in Healthcare (ISQua). He served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services.

Eyal earned his MD at the Technion Israel Institute of Technology and an MSc in Healthcare Management from the Harvard School of Public Health.

Ofir Hazut is an Expert in Residence at Shoni Health Ventures.

Ofir brings over 15 years of experience as a HealthTech venture investor, serial entrepreneur, and board member across medical devices, digital health, biotech, and AI-driven healthcare.

Previously, Ofir served as VP of Medical Investments at Trendlines Investments, a leading early-stage investment firm. In this role, he led HealthTech investments from sourcing and due diligence through deal execution and post-investment value creation. During his tenure, he managed and supported a portfolio of more than 35 HealthTech startups and was involved in multiple portfolio exits. Ofir worked closely with founders, management teams, and boards, supporting fundraising, clinical strategy, regulatory planning, commercialization, and complex strategic processes.

Prior to Trendlines, Ofir was a Principal at Agate Medical Investments, a VC focusing on growth-stage HealthTech investments, and Director of Strategy at Evogene (NASDAQ: EVGN), where he led spin-off strategy, global partnerships, and commercialization initiatives for AI-driven life-science platforms. Ofir also co-founded and led several MedTech and Digital Health startups, raising capital from strategic and institutional investors and advancing products through development and early market entry.

Ofir earned an M.Sc. in Neuroscience from Tel Aviv University and an MBA in Information Technology and Entrepreneurship from Bar-Ilan University.

Ben is a Senior Analyst & Deal Flow Manager at Shoni Health Ventures.

He earned his Doctor of Medicine degree from Ben-Gurion University of the Negev where he also served as the Head Teaching Assistant in anatomy, further solidifying his understanding of complex clinical topics.

In recent years, he gained valuable hands-on experience in Orthopedics and Internal Medicine, working as a Physician Assistant at leading hospitals, such as Sheba, Ichilov, and Meir. Prior to medical studies, Ben applied his strong analytical skillset as a psychometric test (Israeli SAT) instructor, helping students excel in standardized testing.

With a solid medical background and a commitment to advancing healthcare innovation, Ben is well equipped to assess and support innovative health technologies. He is working as a Junior Doctor at the Sheba Medical Center.

Evan is the Managing Partner for SPRIG Equity and serves on several boards of HealthTech companies. Previously, he was a General Partner at Accelmed Partners. He also spent a decade at Abbott Labs leading the corporate venture arm, Abbott Ventures. Prior to Abbott, he was a Principal with ONSET Ventures focusing on HealthTech investing. He has a diverse background of operating experience in HealthTech including the endoscopy, diabetes and ear, nose and throat markets, having worked for Stryker Endoscopy, J&J LifeScan and Acclarent.

In addition to his medical device experience, Evan worked for the Investment Banking Group at J.P. Morgan Chase & Co and in the consulting practice at PricewaterhouseCoopers.

Evan earned his MBA degree from the J.L. Kellogg Graduate School of Management and a BBA cum laude in Finance from Texas A&M University. He currently is an adjunct professor at Kellogg (Medical Products Commercialization and Funding) and serves on the Innovation and New Ventures Advisory Board and N.XT Fund investment committee at Northwestern University. Evan has lectured at numerous business schools including the Coller School at Tel Aviv University and Duke’s Fuqua School.

Steve is the former President, Thomas Jefferson University & CEO, Jefferson Health (2013-2021). Under his leadership, Jefferson grew from 3 hospitals to 18 and in annual revenues from $1.8B to $9B.

He now serves as Executive in Residence at General Catalyst, as Operating Partner and Chief Medical Officer at Abundant Venture Partners and as Chief Strategy Officer for Global Growth at the Sheba Medical Center.

Steve was listed several times on Modern Healthcare magazine’s “100 Most Influential People in Healthcare” annual list, and is an internationally recognized advocate for transformation in healthcare and higher education. In 2019, he spoke about the Future of Hospitals at the World Economic Forum in Davos, and in 2020, was named a Distinguished Fellow of the World Economic Forum.

Steve earned his Bachelor of Science in Chemistry and Biology from Lehigh University in Bethlehem, Pennsylvania. He holds an MD from Hahnemann University, Philadelphia and an MBA from the Wharton Executive Program of the University of Pennsylvania, Philadelphia. He served as Professor of Obstetrics and Gynecology at Penn State University Hershey Medical Center, Drexel University, the University of South Florida as well as Thomas Jefferson University.

For over two decades Chip has served as the President and CEO of the Federation of American Hospitals, the national advocacy organization for investor-owned hospitals. Previously, he was the President and CEO of the Health Insurance Association of America where he served an earlier stint as Executive Vice President.

Chip also had a long and distinguished career as a professional staffer in the US Congress, specializing in health care financing and delivery policy. He worked many years both in the Senate and the House of Representatives and from 1995-1998 as staff director for the Health Subcommittee of the House Ways and Means Committee and played a keystone role in writing the most significant health legislation of that period.

Chip was a co-founder and principal of the former Hospital Quality Alliance (HQA), a private-public partnership, and served as a Commissioner of the American Health Information Community, a former Department of Health and Human Services (HHS) policy advisory panel responsible for advising then-HHS Secretary Michael Leavitt about the diffusion of health information technology. For many years he has served as a co-chair of the National Quality Forum’s Measure Application Partnership’s Coordinating Committee.

He is the only Healthcare leader who has appeared on Modern Healthcare magazine’s “100 Most Influential People in Healthcare” annual list since its inception, and his professional experience combined with volunteer efforts led to him being honored with the B’nai B’rith National Health Care Award in 2016. He frequently writes about the topic of healthcare performance measurement in publications such as Health Affairs, as well as serving on the boards of several companies and foundations.

Chip earned his BA from Johns Hopkins University and an MPH from Tulane University and has taught health policy at both universities as well as George Washington University.